Ysios Capital

Ysios Capital is a prominent Spanish venture capital firm specializing in providing private equity financing to early and mid-stage life science companies focused on developing innovative therapeutic products. With over €400 million in assets under management across three dedicated funds, the firm is committed to transforming capital into medical breakthroughs that address high unmet medical needs. Their diverse international team, based in San Sebastián and Barcelona, is driven by a passion for science and a dedication to improving patient outcomes.

The firm's investment strategy centers on identifying exceptional teams with pioneering science and the drive to change patients' lives. Ysios Capital focuses exclusively on innovative therapeutic drugs, seeking companies that bring life-changing treatments to patients, particularly in areas with significant unmet needs. Their portfolio includes a mix of biotech companies located across Europe and the United States, all of which have a high potential to make a meaningful impact in the healthcare sector.

Since its inception in 2008, Ysios Capital has achieved notable success, with 19 medical products brought from lab to market and over 70 products at the clinical stage for serious diseases. The firm has also established more than 100 collaborations with leading research institutions and invested over €1,000 million in therapeutic R&D. This track record underscores their commitment to fostering innovation and advancing healthcare solutions globally.